Michael Freeman Analyst PerformanceResearch Analyst Healthcare at Raymond James FinancialMichael Freeman is a stock analyst at Raymond James Financial focused in the healthcare sector, covering 12 publicly traded companies. Over the past year, Michael Freeman has issued 1 stock ratings, including and strong buy recommendations. While full access to Michael Freeman's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Freeman's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings17 Last 2 YearsBuy Recommendations100.00% 17 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution17RatingsDistribution of strong buy, buy, hold, and sell ratings by Michael Freeman.RatingPercentageCount Strong Buy35.3%6 ratings Buy64.7%11 ratings Hold0.0%0 ratings Sell0.0%0 ratingsOut of 17 total stock ratings issued by Michael Freeman at Raymond James Financial, the majority (64.7%) have been Buy recommendations, followed by 35.3% Strong Buy.Best & Worst CallsBest Call000.0%IRONJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%RNAJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ58.3% of companies on NASDAQ7 companiesTSE41.7% of companies on TSE5 companiesMichael Freeman, an analyst at Raymond James Financial, currently covers 12 companies listed on NASDAQ and TSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare11 companies91.7%Miscellaneous1 company8.3%Michael Freeman of Raymond James Financial specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY6 companies50.0%PHARMACEUTICALS3 companies25.0%HEALTHCARE TECHNOLOGY1 company8.3%HEALTHCARE EQUIPMENT & SUPPLIES1 company8.3%Miscellaneous1 company8.3% About Michael FreemanMichael W. Freeman joined Raymond James Ltd. in 2019 and was promoted in 2024 to lead Canadian coverage of healthcare services, healthcare software, biotechnology, medical technology, and pharmaceuticals. Michael is a Brendan Wood International TopGun ranked analyst. Prior to joining Raymond James Ltd., he was an equity research associate covering healthcare and biotechnology at a boutique investment bank in Toronto, and was a process engineer at WSP Global, an international strategic advisory and engineering services firm. He holds an MASc in chemical engineering focused on the development of nanomedicines for cancer treatment from the University of Toronto and a BASc in chemical engineering focused on biological engineering and process chemistry from Queen’s University.Follow on LinkedIn Michael Freeman's Ratings History at Raymond James Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTECXTectonic Therapeutic5/26/2026Upgrade$29.12$81.00Strong-Buy$0.0000.00% ROIVHIVitalhub6/20/2025Boost Price TargetC$11.16C$14.00Outperform$0.0000.00% ROIRNAAvidity Biosciences6/11/2025Initiated Coverage$33.62$65.00Strong-Buy$00.0000.00% ROIWVEWAVE Life Sciences6/11/2025Initiated Coverage$7.28$14.00Outperform$0.0000.00% ROITECXTectonic Therapeutic6/11/2025Initiated Coverage$25.04$76.00Outperform$00.0000.00% ROIIRONDisc Medicine6/11/2025Initiated Coverage$52.22$89.00Strong-Buy$00.0000.00% ROIPROFProfound Medical5/9/2025Downgrade$4.28Moderate Buy$0.0000.00% ROIPRNProfound Medical5/9/2025DowngradeC$6.00Moderate Buy$0.0000.00% ROIVHIVitalhub3/26/2025UpgradeC$9.66Moderate Buy$0.0000.00% ROIACOGAlpha Cognition3/25/2025Upgrade$5.52Moderate Buy$0.0000.00% ROIMDPMedexus Pharmaceuticals1/8/2025UpgradeC$3.59C$4.00Strong-Buy$0.0000.00% ROIMDPMedexus Pharmaceuticals11/20/2024UpgradeC$2.15C$4.00Outperform$0.0000.00% ROIGUDKnight Therapeutics11/15/2024UpgradeC$5.19Moderate Buy$0.0000.00% ROIONCOncolytics Biotech11/14/2024UpgradeC$1.38Moderate Buy$00.0000.00% ROIONCYOncolytics Biotech11/14/2024Upgrade$0.98Moderate Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
